<DOC>
	<DOCNO>NCT00909766</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability effect body weight obesity-related factor different dos BMS-830216 , compare placebo . The study also determine amount BMS-830216 blood .</brief_summary>
	<brief_title>Safety , Pharmacokinetics Pharmacodynamics Study Evaluate BMS-830216 Obese Subjects</brief_title>
	<detailed_description />
	<criteria>Obese subject determine clinically significant deviation normal medical history , physical examination , ECGs , clinical laboratory determination Body Mass Index ( BMI ) 30 40 kg/m² , inclusive Women childbearing potential ( ie , postmenopausal surgically sterile ) men , age 18 55 , inclusive Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECG clinical laboratory determination beyond consistent target population Female childbearing potential Sexually active fertile male use effective birth control method ( example , condom ) partner females childbearing potential Abnormal blood work result ( example , triglyceride ≥ 400 mg/dL , glucose ≥126 mg/dL total cholesterol ≥ 300 mg/dL ) High blood pressure ( ≥160/95 mm Hg ) Major surgical procedure within 4 week prior randomization Chronic infection ( e.g. , HIV [ human immunodeficiency virus ] Hepatitis C ) Clinically significant history presence follow condition : heart , liver , kidney disease , neurologic psychiatric disease , previous surgery weight loss History gastrointestinal disease within past 3 month History Type I Type II diabetes past 12 month A lifetime history suicide attempt history suicidal behavior past month Any clinically significant medical condition could potentially affect participation study and/or personal wellbeing , judge investigator Used grapefruit grapefruit juice within 1 week prior randomization Donated blood blood product blood bank , blood transfusion participate clinical study ( except screen visit ) require withdrawal blood within 4 week prior randomization Unable tolerate oral and/or intravenous ( IV ) medication Unable tolerate puncturing vein draw blood Prior exposure BMS830216 History prior weight loss ( example , gastric bypass gastric banding ) gastrointestinal surgery could impact absorption study drug History Major Depressive Disorder within past 2 year Known allergy hypersensitivity component study medication History significant drug allergy ( anaphylaxis hepatotoxicity ) Used oral , injectable implantable hormonal contraceptive agent ( example , birth control pill , DepoProvera , NuvaRing ) within 3 month prior randomization Used prescription drug counter product control acid ( example , Prevacid , Mylanta Rolaids ) within 4 week prior randomization Used prescription drug , counter medication herbal preparation within 1 week prior randomization Taken St. John 's Wort within 1 week prior randomization Taken investigational drug placebo ( inactive drug ) within 4 week prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>